Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)

McMaster University

$100,000.00

Systematic single-cell characterization of coordinated RNA regulatory mechanisms underlying glioblastoma progression

FY 2023-24

Summary
Adult brain tumors are rarely curative and urgently need novel treatments. Glioblastoma (GBM) is the most common type of primary brain tumor in adults with devastating neurological symptoms. It is also the most aggressive and lethal. Despite current treatment efforts, tumor re-growth is inevitable in GBM patients. Understanding mechanisms that drive rapid changes and dynamic interactions between a patient's tumor and its surrounding tissue environment is a key aspect of conquering GBM. Alternative splicing (AS) represents a widely acting gene regulatory mechanism, allowing a single gene to generate multiple protein products. Almost all human genes are alternatively spliced. AS can impact every aspect of cancer, providing opportunities to uncover new mechanisms and therapeutic targets. Our proposed research aims to establish innovative technology platforms to discover and characterize AS regulation and its coordination with other gene regulatory mechanisms underlying GBM biology. Leveraging the power of systematic experimental and data science approaches, together with unique patient GBM and disease model studies, we will illustrate how GBM changes its behavior in time and space to impact disease progression, therapy response, and relapse at the level of single cells. Together, our study will link multilevel genetic information to provide in-depth mechanistic insights and discover novel GBM therapeutics. Moreover, the framework and methods we built are highly translatable to investigate diverse hard-to-treat cancers, facilitating the development of a new generation of splicing-directed therapeutic strategies.
Program
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
495059
Name
Han Hong
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genomics: Systems and computational biology
Projecttitle
Systematic single-cell characterization of coordinated RNA regulatory mechanisms underlying glioblastoma progression
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Keyworddelim
Bioinformatics; Cancer Progression; Functional Genomics; Gene Regulation; Glioblastoma; Recurrence; Rna Splicing; Single-Cell Omics; Systems Biology; Tumor Ecosystem
Abstract
Adult brain tumors are rarely curative and urgently need novel treatments. Glioblastoma (GBM) is the most common type of primary brain tumor in adults with devastating neurological symptoms. It is also the most aggressive and lethal. Despite current treatment efforts, tumor re-growth is inevitable in GBM patients. Understanding mechanisms that drive rapid changes and dynamic interactions between a patient's tumor and its surrounding tissue environment is a key aspect of conquering GBM. Alternative splicing (AS) represents a widely acting gene regulatory mechanism, allowing a single gene to generate multiple protein products. Almost all human genes are alternatively spliced. AS can impact every aspect of cancer, providing opportunities to uncover new mechanisms and therapeutic targets. Our proposed research aims to establish innovative technology platforms to discover and characterize AS regulation and its coordination with other gene regulatory mechanisms underlying GBM biology. Leveraging the power of systematic experimental and data science approaches, together with unique patient GBM and disease model studies, we will illustrate how GBM changes its behavior in time and space to impact disease progression, therapy response, and relapse at the level of single cells. Together, our study will link multilevel genetic information to provide in-depth mechanistic insights and discover novel GBM therapeutics. Moreover, the framework and methods we built are highly translatable to investigate diverse hard-to-treat cancers, facilitating the development of a new generation of splicing-directed therapeutic strategies.
Competitiondate
202309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Han, Hong
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
McMaster University - $100,000 Grant (2023-24) | Canada Spends